Oulu, Finland

Leena Hirvelae

This inventor holds 2 USPTO granted patents. Top assignees: Solvay Pharmaceuticals, B.v., Solvay Pharmaceuticals, Gmbh. Active years: 2008-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leena Hirvelae. Retrieved from https://idiyas.com/inventor/leena-hirvelae

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Leena Hirvelae: Innovator in Therapeutic Compounds

Introduction

Leena Hirvelae is a notable inventor based in Oulu, Finland. She has made significant contributions to the field of therapeutic compounds, particularly in the treatment of steroid hormone-dependent diseases. With a total of two patents to her name, her work is recognized for its potential impact on medical therapies.

Latest Patents

Leena's latest patents focus on Thiophenepyrimidinone compounds and their therapeutic applications. These compounds are particularly aimed at the treatment and prevention of steroid hormone-dependent diseases or disorders. They are designed to inhibit 17β-hydroxysteroid dehydrogenase enzymes, which play a crucial role in the metabolism of steroid hormones.

Career Highlights

Throughout her career, Leena has worked with prominent companies such as Solvay Pharmaceuticals B.V. and Solvay Pharmaceuticals GmbH. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations and therapeutic solutions.

Collaborations

Leena has collaborated with several professionals in her field, including Nina Johansson and Pasi Koskimies. These collaborations have contributed to her research and development efforts in creating effective therapeutic compounds.

Conclusion

Leena Hirvelae stands out as an innovative inventor in the realm of therapeutic compounds. Her work continues to pave the way for advancements in the treatment of steroid hormone-dependent diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…